Literature DB >> 32581135

Biology of antimicrobial resistance and approaches to combat it.

Sarah M Schrader1, Julien Vaubourgeix2, Carl Nathan3.   

Abstract

Insufficient development of new antibiotics and the rising resistance of bacteria to those that we have are putting the world at risk of losing the most widely curative class of medicines currently available. Preventing deaths from antimicrobial resistance (AMR) will require exploiting emerging knowledge not only about genetic AMR conferred by horizontal gene transfer or de novo mutations but also about phenotypic AMR, which lacks a stably heritable basis. This Review summarizes recent advances and continuing limitations in our understanding of AMR and suggests approaches for combating its clinical consequences, including identification of previously unexploited bacterial targets, new antimicrobial compounds, and improved combination drug regimens.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2020        PMID: 32581135      PMCID: PMC8177555          DOI: 10.1126/scitranslmed.aaz6992

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  142 in total

1.  Slow growth determines nonheritable antibiotic resistance in Salmonella enterica.

Authors:  Mauricio H Pontes; Eduardo A Groisman
Journal:  Sci Signal       Date:  2019-07-30       Impact factor: 8.192

Review 2.  Clarifying the Link between Toxin-Antitoxin Modules and Bacterial Persistence.

Authors:  Séverin Ronneau; Sophie Helaine
Journal:  J Mol Biol       Date:  2019-03-23       Impact factor: 5.469

3.  Bacterial Factors That Predict Relapse after Tuberculosis Therapy.

Authors:  Roberto Colangeli; Hannah Jedrey; Soyeon Kim; Roy Connell; Shuyi Ma; Uma D Chippada Venkata; Soumitesh Chakravorty; Aditi Gupta; Erin E Sizemore; Lois Diem; David R Sherman; Alphonse Okwera; Reynaldo Dietze; W Henry Boom; John L Johnson; William R Mac Kenzie; David Alland
Journal:  N Engl J Med       Date:  2018-08-30       Impact factor: 91.245

4.  Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance.

Authors:  Hassan Safi; Pooja Gopal; Subramanya Lingaraju; Shuyi Ma; Carly Levine; Veronique Dartois; Michelle Yee; Liping Li; Landry Blanc; Hsin-Pin Ho Liang; Seema Husain; Mainul Hoque; Patricia Soteropoulos; Tige Rustad; David R Sherman; Thomas Dick; David Alland
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-05       Impact factor: 11.205

5.  A common mechanism of cellular death induced by bactericidal antibiotics.

Authors:  Michael A Kohanski; Daniel J Dwyer; Boris Hayete; Carolyn A Lawrence; James J Collins
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

Review 6.  Microbial persistence and the road to drug resistance.

Authors:  Nadia R Cohen; Michael A Lobritz; James J Collins
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

7.  Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells.

Authors:  Yingying Pu; Zhilun Zhao; Yingxing Li; Jin Zou; Qi Ma; Yanna Zhao; Yuehua Ke; Yun Zhu; Huiyi Chen; Matthew A B Baker; Hao Ge; Yujie Sun; Xiaoliang Sunney Xie; Fan Bai
Journal:  Mol Cell       Date:  2016-04-21       Impact factor: 17.970

8.  Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum.

Authors:  Jansy P Sarathy; Laura E Via; Danielle Weiner; Landry Blanc; Helena Boshoff; Eliseo A Eugenin; Clifton E Barry; Véronique A Dartois
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

9.  Bacterial persistence is an active σS stress response to metabolic flux limitation.

Authors:  Jakub Leszek Radzikowski; Silke Vedelaar; David Siegel; Álvaro Dario Ortega; Alexander Schmidt; Matthias Heinemann
Journal:  Mol Syst Biol       Date:  2016-09-21       Impact factor: 11.429

10.  Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis.

Authors:  Murat Cokol; Nurdan Kuru; Ece Bicak; Jonah Larkins-Ford; Bree B Aldridge
Journal:  Sci Adv       Date:  2017-10-11       Impact factor: 14.136

View more
  22 in total

1.  Enhancement of the Bactericidal Effect of Antibiotics by Inhibition of Enzymes Involved in Production of Hydrogen Sulfide in Bacteria.

Authors:  T A Seregina; K V Lobanov; R S Shakulov; A S Mironov
Journal:  Mol Biol       Date:  2022-10-05       Impact factor: 1.540

2.  Green Synthesized Silver Nanoparticles Using Lactobacillus Acidophilus as an Antioxidant, Antimicrobial, and Antibiofilm Agent Against Multi-drug Resistant Enteroaggregative Escherichia Coli.

Authors:  Padikkamannil Abishad; Jess Vergis; Varsha Unni; Vemula Prasastha Ram; Pollumahanti Niveditha; Jyothsana Yasur; Sanis Juliet; Lijo John; Kullaiya Byrappa; Prejit Nambiar; Nitin Vasantrao Kurkure; Sukhadeo Baliram Barbuddhe; Deepak Bhiwa Rawool
Journal:  Probiotics Antimicrob Proteins       Date:  2022-06-17       Impact factor: 5.265

3.  Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected.

Authors:  Kohta Saito; Saurabh Mishra; Thulasi Warrier; Nico Cicchetti; Jianjie Mi; Elaina Weber; Xiuju Jiang; Julia Roberts; Alexandre Gouzy; Ellen Kaplan; Christopher D Brown; Ben Gold; Carl Nathan
Journal:  Sci Transl Med       Date:  2021-11-24       Impact factor: 19.319

4.  Multiform antimicrobial resistance from a metabolic mutation.

Authors:  Sarah M Schrader; Hélène Botella; Robert Jansen; Sabine Ehrt; Kyu Rhee; Carl Nathan; Julien Vaubourgeix
Journal:  Sci Adv       Date:  2021-08-27       Impact factor: 14.136

Review 5.  Applications of Machine Learning to the Problem of Antimicrobial Resistance: an Emerging Model for Translational Research.

Authors:  Melis N Anahtar; Jason H Yang; Sanjat Kanjilal
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

Review 6.  Approaches for characterizing and tracking hospital-associated multidrug-resistant bacteria.

Authors:  Kevin S Blake; JooHee Choi; Gautam Dantas
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

Review 7.  Heterogeneous Host-Pathogen Encounters Coordinate Antibiotic Resilience in Mycobacterium tuberculosis.

Authors:  Richa Mishra; Vikas Yadav; Madhura Guha; Amit Singh
Journal:  Trends Microbiol       Date:  2020-12-10       Impact factor: 17.079

8.  Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA.

Authors:  Yimin Li; Pengfei She; Lanlan Xu; Yaqian Liu; Shasha Liu; Zehao Li; Yifan Yang; Linhui Li; Zubair Hussain; Yong Wu
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-26       Impact factor: 4.813

Review 9.  Type IA Topoisomerases as Targets for Infectious Disease Treatments.

Authors:  Ahmed Seddek; Thirunavukkarasu Annamalai; Yuk-Ching Tse-Dinh
Journal:  Microorganisms       Date:  2021-01-01

Review 10.  Antibiofilm Peptides: Relevant Preclinical Animal Infection Models and Translational Potential.

Authors:  Gislaine G O S Silveira; Marcelo D T Torres; Camila F A Ribeiro; Beatriz T Meneguetti; Cristiano M E Carvalho; Cesar de la Fuente-Nunez; Octávio L Franco; Marlon H Cardoso
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.